Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedAug 28, 2026
DataAggregated Company Financials
Companies5
  • 7D0.3%
  • 3M-3.7%
  • 1Y-39.4%
  • YTDn/a

In the last week, Drug Retail has been flat. Unfortunately though, the industry is down 39% over the past 12 months. Earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 28 Aug 2026NT$19.1bNT$34.3bNT$753.1m19.8x25.3x0.6x
Sun, 26 Jul 2026NT$20.1bNT$34.3bNT$765.8m22.6x26.2x0.6x
Tue, 23 Jun 2026NT$19.9bNT$34.3bNT$765.8m22.4x26x0.6x
Thu, 21 May 2026NT$19.4bNT$34.3bNT$765.8m22.1x25.3x0.6x
Sat, 18 Apr 2026NT$21.3bNT$34.3bNT$687.6m20.2x31x0.6x
Mon, 16 Mar 2026NT$21.2bNT$34.2bNT$695.1m20.7x30.5x0.6x
Wed, 11 Feb 2026NT$23.1bNT$33.9bNT$712.6m21.9x32.5x0.7x
Fri, 09 Jan 2026NT$21.0bNT$33.9bNT$712.6m19.3x29.4x0.6x
Sun, 07 Dec 2025NT$22.5bNT$33.9bNT$712.6m21x31.5x0.7x
Tue, 04 Nov 2025NT$25.0bNT$33.5bNT$755.9m24.5x33.1x0.7x
Thu, 02 Oct 2025NT$28.1bNT$33.5bNT$755.9m28.5x37.2x0.8x
Sat, 30 Aug 2025NT$30.9bNT$33.5bNT$755.9m31.6x40.9x0.9x
Mon, 28 Jul 2025NT$31.2bNT$32.8bNT$754.7m27.4x41.3x0.9x
Wed, 25 Jun 2025NT$30.1bNT$32.8bNT$754.7m28.1x39.9x0.9x
Fri, 23 May 2025NT$32.4bNT$32.8bNT$754.7m31.1x42.9x1x
Sun, 20 Apr 2025NT$31.9bNT$32.3bNT$718.2m38.4x44.4x1x
Tue, 18 Mar 2025NT$37.8bNT$32.1bNT$701.3m45.6x53.8x1.2x
Thu, 13 Feb 2025NT$33.8bNT$31.8bNT$755.8m41.6x44.7x1.1x
Sat, 11 Jan 2025NT$32.4bNT$31.8bNT$755.8m43.3x42.8x1x
Mon, 09 Dec 2024NT$35.9bNT$31.8bNT$755.8m46.2x47.5x1.1x
Wed, 06 Nov 2024NT$39.1bNT$31.4bNT$774.1m112.6x50.5x1.2x
Fri, 04 Oct 2024NT$41.4bNT$31.0bNT$840.8m113.9x49.3x1.3x
Sun, 01 Sep 2024NT$41.4bNT$31.0bNT$840.8m112.5x49.3x1.3x
Tue, 30 Jul 2024NT$43.2bNT$30.7bNT$873.1m79.7x49.5x1.4x
Thu, 27 Jun 2024NT$45.5bNT$30.7bNT$873.1m80x52.1x1.5x
Sat, 25 May 2024NT$48.3bNT$30.7bNT$873.1m83.1x55.3x1.6x
Mon, 22 Apr 2024NT$48.7bNT$30.3bNT$935.7m57.9x52x1.6x
Wed, 20 Mar 2024NT$54.0bNT$30.2bNT$941.1m56.7x57.4x1.8x
Fri, 16 Feb 2024NT$54.5bNT$29.9bNT$964.0m60.4x56.5x1.8x
Sun, 14 Jan 2024NT$52.9bNT$26.8bNT$949.0m58.5x55.7x2x
Tue, 12 Dec 2023NT$53.1bNT$26.8bNT$949.0m58.8x56x2x
Thu, 09 Nov 2023NT$54.2bNT$26.3bNT$1.0b46.4x53x2.1x
Sat, 07 Oct 2023NT$57.7bNT$26.3bNT$1.0b48.1x56.5x2.2x
Mon, 04 Sep 2023NT$54.0bNT$26.3bNT$1.0b46.1x52.9x2.1x
Price to Earnings Ratio

52.9x


Total Market Cap: NT$54.0bTotal Earnings: NT$1.0bTotal Revenue: NT$26.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 43.4x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 25.3x which is lower than its 3-year average PE of 43.4x.
  • The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.56x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 9.6% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market2.34%
Consumer Staples-0.47%
Food and Staples Retail0.29%
Drug Retail0.29%
Food Distributors0.67%
Food Retail0.28%
Big Box Super Stores0%0
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7731 MARX BiotechNT$4.482.1%
+NT$47.0m		-2.2%PE73.1x
6844 Norbel BabyNT$60.400.8%
+NT$18.7m		-38.5%PE18.4x
4175 MedFirst Healthcare ServicesNT$51.400.4%
+NT$8.5m		-15.9%PE13.6x

Latest News

4175
NT$51.40
MedFirst Healthcare Services
7D
0.4%
1Y
-15.9%
6929
NT$22.80
We Can Medicines
7D
-2.4%
1Y
-29.2%
6844
NT$60.40
Norbel Baby
7D
0.8%
1Y
-38.5%
7731
NT$4.48
MARX Biotech
7D
2.1%
1Y
-2.2%